HIV Infection Is an Independent Predictor of Mortality Among Adults with Reduced Level of Consciousness in Uganda.


Journal

The American journal of tropical medicine and hygiene
ISSN: 1476-1645
Titre abrégé: Am J Trop Med Hyg
Pays: United States
ID NLM: 0370507

Informations de publication

Date de publication:
17 01 2022
Historique:
received: 19 07 2021
accepted: 02 11 2021
pubmed: 14 1 2022
medline: 26 4 2022
entrez: 13 1 2022
Statut: epublish

Résumé

The clinical epidemiology of adults admitted with reduced level of consciousness (LOC) in sub-Saharan Africa (SSA) and the impact of HIV infection on the risk of mortality in this population is unknown. We secondarily analyzed data from a cohort study that enrolled 359 consecutive adults with reduced LOC presenting to Mbarara Regional Hospital in Uganda with the aim of comparing the prognostic utility of the Full Outline of Unresponsiveness (FOUR) score to the Glasgow Coma Scale (GCS) Score. For this analysis, we included 336 individuals with known HIV serostatus, obtaining clinical, laboratory, and follow-up data. We recorded investigations and treatments deemed critical by clinicians for patient care but were unavailable. We computed mortality rates and used logistic regression to determine predictors of 30-day mortality. The median GCS was 10. Persons living with HIV infection (PLWH) accounted for 97 of 336 (29%) of the cohort. The 30-day mortality rate in the total cohort was 148 of 329 (45%), and this was significantly higher in PLWH (57% versus 40%, adjusted odds ratio [aOR] 2.39: 95% confidence interval [CI]: 1.31-4.35, P = 0.0046). Other predictors of mortality were presence of any unmet clinical need (aOR 1.72; 95% CIL 1.04-2.84, P = 0.0346), anemia (aOR 1.68; 95% CI: 1.01-2.81, P = 0.047), and admission FOUR score < 12 [aOR 4.26; 95% CI: 2.36-7.7, P < 0.0001). Presentation with reduced LOC in Uganda is associated with high mortality rates, with worse outcomes in PLWH. Improvement of existing acute care services is likely to improve outcomes.

Identifiants

pubmed: 35026731
doi: 10.4269/ajtmh.21-0813
pmc: PMC8922480
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

909-914

Références

PLoS One. 2019 May 14;14(5):e0216060
pubmed: 31086371
PLoS One. 2009 Nov 11;4(11):e7782
pubmed: 19907656
Neurocrit Care. 2020 Jun;32(3):734-741
pubmed: 31392656
Curr HIV/AIDS Rep. 2016 Oct;13(5):289-96
pubmed: 27541600
PLoS Med. 2017 Jul 25;14(7):e1002357
pubmed: 28742880
S Afr Med J. 1980 May 10;57(19):771-4
pubmed: 7404014
East Afr Med J. 1997 Jan;74(1):49-53
pubmed: 9145579
J Leukoc Biol. 2020 Apr;107(4):597-612
pubmed: 31965635
PLoS One. 2019 Jul 3;14(7):e0218902
pubmed: 31269056
J Int AIDS Soc. 2014 Apr 07;17:18797
pubmed: 24713375
Niger Postgrad Med J. 2011 Mar;18(1):1-7
pubmed: 21445104
AIDS Res Treat. 2011;2011:180352
pubmed: 22216407
QJM. 1996 Jul;89(7):499-504
pubmed: 8759489
J Acquir Immune Defic Syndr. 2016 Dec 1;73(4):426-432
pubmed: 27228100
Int J Gen Med. 2019 Nov 06;12:395-403
pubmed: 31819592
J Neurol Sci. 1999 Jan 1;162(1):20-6
pubmed: 10064164
Lancet Public Health. 2017 Jan;2(1):e35-e46
pubmed: 29249478
Econ Hum Biol. 2017 Nov;27(Pt A):248-260
pubmed: 28930699
Emerg Med Clin North Am. 2010 May;28(2):311-23, Table of Contents
pubmed: 20413014
Sex Transm Infect. 2007 Apr;83(2):85-6
pubmed: 17435051
Trop Doct. 2009 Oct;39(4):240-1
pubmed: 19762582
J Crit Care. 2020 Feb;55:95-99
pubmed: 31715537
BMC Proc. 2011 Jun 13;5 Suppl 5:S2
pubmed: 21810212

Auteurs

Amir A Mbonde (AA)

Department of Internal Medicine, Mbarara University of Science and Technology, Uganda.
Department of Neurology, Mayo Clinic College of Medicine and Science, Phoenix, Arizona.

Lydia Mbatidde (L)

College of Science and Engineering, St. Cloud State University, New Hope, Minnesota.

Bart M Demaerschalk (BM)

Department of Neurology, Mayo Clinic College of Medicine and Science, Phoenix, Arizona.

Abdirahim A Aden (AA)

Department of Internal Medicine, Healthgate Hospital, Nairobi, Kenya.

Nan Zhang (N)

Department of Quantitative Health Sciences, Division of Clinical Trials and Biostatistics, Mayo Clinic, Phoenix, Arizona.

Richard Butterfield (R)

Department of Quantitative Health Sciences, Division of Clinical Trials and Biostatistics, Mayo Clinic, Phoenix, Arizona.

Rose Muhindo (R)

Department of Internal Medicine, Mbarara University of Science and Technology, Uganda.

Adrian Kayanja (A)

Department of Internal Medicine, Mbarara University of Science and Technology, Uganda.

Cumara B O'Carroll (CB)

Department of Neurology, Mayo Clinic College of Medicine and Science, Phoenix, Arizona.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH